Death (any cause) · people with CKD who are overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (3.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (1.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · heart failure with chronic kidney disease
ACUTE: Serelaxin showed no clear difference in death (any cause) compared with placebo (low certainty).
1 finding from 1 review
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) ( · heart failure with chronic kidney disease
CHRONIC: ACEi or ARB showed no clear difference in death (any cause) ( compared with placebo (low certainty).
1 finding from 1 review
Death (any cause) ( · heart failure with chronic kidney disease
CHRONIC: Beta‐blockers probably leads to lower death (any cause) ( compared with placebo (moderate certainty).
1 finding from 1 review
Death (any cause) ( · heart failure with chronic kidney disease
It is very uncertain whether CHRONIC: Aldosterone antagonists changes death (any cause) ( compared with placebo (very low certainty).
1 finding from 1 review
Death from any cause · AKI patients receiving CKRT
It is very uncertain whether CVVHD changes death from any cause compared with CVVH or CVVHDF (very low certainty).
1 finding from 1 review
Death (any cause) (median · people with ESKD
Counselling showed no clear difference in death (any cause) (median compared with usual care (low certainty).
1 finding from 1 review
Death (any cause) (median · people with ESKD
Cognitive‐behavioural therapy showed no clear difference in death (any cause) (median compared with usual care (low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether long (> 20 cm) changes death from any cause at day 28 of compared with short (≤ 20 cm) catheter (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).
1 finding from 1 review